1. Grino PB, Griffin JE, Wilson JD (1990) Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 126: 1165-1172.
2. Heemers HV, Tindall DJ (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28: 778-808.
3. Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360.
4. Jenster G, Trapman J, Brinkmann AO (1993) Nuclear import of the human androgen receptor. Biochem J 293 ( Pt 3): 761-768.
5. Wilson S, Qi J, Filipp FV (2016) Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines. Sci Rep 6: 32611.
6. Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD (2003) Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol 4: R37.
7. Appari M, Werner R, Wunsch L, Cario G, Demeter J, et al. (2009) Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. J Mol Med (Berl) 87: 623-632.
8. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, et al. (2000) Apolipoprotein D. Biochim Biophys Acta 1482: 185-198.
9. Simard J, Veilleux R, de Launoit Y, Haagensen DE, Labrie F (1991) Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells. Cancer Res 51: 4336- 4341.
10. Koistinen H, Hautala LC, Seppala M, Stenman UH, Laakkonen P, et al. (2009) The role of glycodelin in cell differentiation and tumor growth. Scand J Clin Lab Invest 69: 452-459.
11. Nishida H, Miyagawa S, Matsumaru D, Wada Y, Satoh Y, et al. (2008) Gene expression analyses on embryonic external genitalia: identification of regulatory genes possibly involved in masculinization processes. Congenit Anom (Kyoto) 48: 63-67.
12. Menad R, Fernini M, Smai S, Bonnet X, Gernigon-Spychalowicz T, et al. (2017) GPER1 in sand rat epididymis: Effects of seasonal variations, castration and efferent ducts ligation. Anim Reprod Sci 183: 9-20.
13. Lai CY, Chen CM, Hsu WH, Hsieh YH, Liu CJ (2017) Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma. Int J Med Sci 14: 1263-1267.
14. Quartier A, Chatrousse L, Redin C, Keime C, Haumesser N, et al. (2018) Genes and Pathways Regulated by Androgens in Human Neural Cells, Potential Candidates for the Male Excess in Autism Spectrum Disorder. Biol Psychiatry 84: 239-252.
15. Hughes IA, Nihoul-Fekete C, Thomas B, Cohen-Kettenis PT (2007) Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development. Best Pract Res Clin Endocrinol Metab 21: 351- 365.
16. Witchel SF (2018) Disorders of sex development. Best Pract Res Clin Obstet Gynaecol 48: 90-102.
17. Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M (2012) The androgen receptor gene mutations database: 2012 update. Hum Mutat 33: 887- 894.
18. Lucas-Herald A, Bertelloni S, Juul A, Bryce J, Jiang J, et al. (2016) The Long- Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene. J Clin Endocrinol Metab 101: 3959- 3967.
19. Adachi M, Takayanagi R, Tomura A, Imasaki K, Kato S, et al. (2000) Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343: 856-862.
20. Weidemann W, Peters B, Romalo G, Spindler KD, Schweikert HU (1998) Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor. J Clin Endocrinol Metab 83: 1173-1176.
21. Nerli RB, Guntaka AK, Patne PB, Hiremath MB (2013) Penile growth in response to hormone treatment in children with micropenis. Indian J Urol 29: 288-291.
22. Deng Q, Zhang Z, Wu Y, Yu WY, Zhang J, et al. (2017) Non-Genomic Action of Androgens is Mediated by Rapid Phosphorylation and Regulation of Androgen Receptor Trafficking. Cell Physiol Biochem 43: 223-236.
23. Shihan M, Bulldan A, Scheiner-Bobis G (2014) Non-classical testosterone signaling is mediated by a G-protein-coupled receptor interacting with Gnalpha11. Biochim Biophys Acta 1843: 1172-1181.
24. Crawford BS (1977) Buried penis. Br J Plast Surg 30: 96-99.
25. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
26. Huang da W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
27. Klocker H, Kaspar F, Eberle J, Uberreiter S, Radmayr C, et al. (1992) Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet 50: 1318-1327.
28. Lundberg Giwercman Y, Nikoshkov A, Lindsten K, Bystrom B, Pousette A, et al. (2000) Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor. Horm Res 53: 83-88.
29. Umesono K, Evans RM (1989) Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57: 1139-1146.
30. Sun SC, Zhao H, Liu R, Wang BL, Liu YQ, et al. (2017) [Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells]. Zhonghua Nan Ke Xue 23: 120-124.
31. Collette J, Le Bourhis X, Adriaenssens E (2017) Regulation of Human Breast Cancer by the Long Non-Coding RNA H19. Int J Mol Sci 18.
32. Hornig NC, Ukat M, Schweikert HU, Hiort O, Werner R, et al. (2016) Identification of an AR Mutation-Negative Class of Androgen Insensitivity by Determining Endogenous AR Activity. J Clin Endocrinol Metab 101: 4468-4477. 33.Pascua-Maestro R, Gonzalez E, Lillo C, Ganfornina MD, Falcon-Perez JM, et al. (2018) Extracellular Vesicles Secreted by Astroglial Cells Transport Apolipoprotein D to Neurons and Mediate Neuronal Survival Upon Oxidative Stress. Front Cell Neurosci 12: 526.
34. Lin CS, Ho HC, Gholami S, Chen KC, Jad A, et al. (2001) Gene expression profiling of an arteriogenic impotence model. Biochem Biophys Res Commun 285: 565-569.
35. Pajaniappan M, Glober NK, Kennard S, Liu H, Zhao N, et al. (2011) Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch signaling. Am J Physiol Heart Circ Physiol 301: H784-793.
36. Bastos AN, Oliveira LR, Ferrarez CE, de Figueiredo AA, Favorito LA, et al. (2011) Structural study of prepuce in hypospadias--does topical treatment with testosterone produce alterations in prepuce vascularization? J Urol 185: 2474- 2478.
37. Torres-Estay V, Carreno DV, San Francisco IF, Sotomayor P, Godoy AS, et al. (2015) Androgen receptor in human endothelial cells. J Endocrinol 224: R131-137.
38. Gray LE, Jr., Kelce WR, Monosson E, Ostby JS, Birnbaum LS (1995) Exposure to TCDD during development permanently alters reproductive function in male Long Evans rats and hamsters: reduced ejaculated and epididymal sperm numbers and sex accessory gland weights in offspring with normal androgenic status. Toxicol Appl Pharmacol 131: 108-118.
39. Takemoto K, Nakajima M, Fujiki Y, Katoh M, Gonzalez FJ, et al. (2004) Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol 78: 309-315.
40. Li F, Zhu W, Gonzalez FJ (2017) Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther 178: 18-30. 41.Marchetti PM, Barth JH (2013) Clinical biochemistry of dihydrotestosterone. Ann Clin Biochem 50: 95-107.
42. Kwon YJ, Baek HS, Ye DJ, Shin S, Kim D, et al. (2016) CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/beta-Catenin Signaling via Sp1 Upregulation. PLoS One 11: e0151598.
43. Cui XB, Chen SY (2018) Response Gene to Complement 32 in Vascular Diseases. Front Cardiovasc Med 5: 128.
44. Badea T, Niculescu F, Soane L, Fosbrink M, Sorana H, et al. (2002) RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase. J Biol Chem 277: 502-508.
45. Iida H, Urasoko A, Doiguchi M, Mori T, Toshimori K, et al. (2003) Complementary DNA cloning and characterization of rat spergen-2, a spermatogenic cell-specific gene 2 encoding a 56-kilodalton nuclear protein bearing ankyrin repeat motifs. Biol Reprod 69: 421-429.
46. Zhou J, Du YR, Qin WH, Hu YG, Huang YN, et al. (2009) RIM-BP3 is a manchette-associated protein essential for spermiogenesis. Development 136: 373-382.
47. Buresh-Stiemke RA, Malinowski RL, Keil KP, Vezina CM, Oosterhof A, et al. (2012) Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development. Dev Dyn 241: 2005- 2013.
48. Edenberg HJ (2007) The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 30: 5- 13.
49. Kradolfer D, Floter VL, Bick JT, Furst RW, Rode K, et al. (2016) Epigenetic effects of prenatal estradiol-17beta exposure on the reproductive system of pigs. Mol Cell Endocrinol 430: 125-137.
50. Ohnishi T, Yamada K, Ohba H, Iwayama Y, Toyota T, et al. (2007) A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology 32: 1727-1737.
51. Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, et al. (2007) Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1. J Biol Chem 282: 637-646.
52. Burmenskaya OV, Bozhenko VK, Smolnikova VY, Kalinina EA, Korneeva IE, et al. (2017) Transcription profile analysis of the endometrium revealed molecular markers of the personalized 'window of implantation' during in vitro fertilization. Gynecol Endocrinol 33: 22-27.
53. Rosewell KL, Al-Alem L, Zakerkish F, McCord L, Akin JW, et al. (2015) Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin. Fertil Steril 103: 826-833.
54. Augustyn KD, Jackson MR, Jorns MS (2017) Use of Tissue Metabolite Analysis and Enzyme Kinetics To Discriminate between Alternate Pathways for Hydrogen Sulfide Metabolism. Biochemistry 56: 986-996.
55. Kubo Y, Baba K, Toriyama M, Minegishi T, Sugiura T, et al. (2015) Shootin1-cortactin interaction mediates signal-force transduction for axon outgrowth. J Cell Biol 210: 663-676.
56. Lecine P, Blank V, Shivdasani R (1998) Characterization of the hematopoietic transcription factor NF-E2 in primary murine megakaryocytes. J Biol Chem 273: 7572-7578.
57. Di Tullio A, Passaro D, Rouault-Pierre K, Purewal S, Bonnet D (2017) Nuclear Factor Erythroid 2 Regulates Human HSC Self-Renewal and T Cell Differentiation by Preventing NOTCH1 Activation. Stem Cell Reports 9: 5-11.
58. Kim SJ, Kim HM (2017) Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14. BMB Rep 50: 55-57.
59. Shiio Y, Rose DW, Aur R, Donohoe S, Aebersold R, et al. (2006) Identification and characterization of SAP25, a novel component of the mSin3 corepressor complex. Mol Cell Biol 26: 1386-1397.
60. La Padula V, Staszewski O, Nestel S, Busch H, Boerries M, et al. (2016) HSPB3 protein is expressed in motoneurons and induces their survival after lesion-induced degeneration. Exp Neurol 286: 40-49.
61. Kolb SJ, Snyder PJ, Poi EJ, Renard EA, Bartlett A, et al. (2010) Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach. Neurology 74: 502-506.
62. Goel RK, Miah S, Black K, Kalra N, Dai C, et al. (2013) The unique N- terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1. FEBS J 280: 4539-4559.
63. Zhi Q, Chen H, Liu F, Han Y, Wan D, et al. (2019) Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein. Cancer Sci 110: 118-134.
64. Heath EI, Heilbrun LK, Smith D, Schopperle WM, Ju Y, et al. (2018) Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer. Anticancer Res 38: 6361-6366.
65. Nielsen JS, McNagny KM (2009) The role of podocalyxin in health and disease. J Am Soc Nephrol 20: 1669-1676.
66. Chenaux G, Matt L, Hill TC, Kaur I, Liu XB, et al. (2016) Loss of SynDIG1 Reduces Excitatory Synapse Maturation But Not Formation In Vivo. eNeuro 3.
67. Winter H, Rogers MA, Langbein L, Stevens HP, Leigh IM, et al. (1997) Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet 16: 372-374.
68. Boudkkazi S, Brechet A, Schwenk J, Fakler B (2014) Cornichon2 dictates the time course of excitatory transmission at individual hippocampal synapses. Neuron 82: 848-858.
69. Kim S, Lee K, Choi JH, Ringstad N, Dynlacht BD (2015) Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle. Nat Commun 6: 8087.
70. Jaillard S, Akloul L, Beaumont M, Hamdi-Roze H, Dubourg C, et al. (2016) Array-CGH diagnosis in ovarian failure: identification of new molecular actors for ovarian physiology. J Ovarian Res 9: 63.
71. Xu X, Yoshizaki H, Ishigaki Y, Kubo E, Minato H, et al. (2017) Upregulation of multiple signaling pathways by Dock5 deletion in epithelial cells. Mol Vis 23: 1081-1092.
72. Bartolomei MS, Zemel S, Tilghman SM (1991) Parental imprinting of the mouse H19 gene. Nature 351: 153-155.
73. Tsang WP, Ng EK, Ng SS, Jin H, Yu J, et al. (2010) Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 31: 350-358.
74. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, et al. (2013) The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 52: 101-112.
75. Yanase T, Adachi M, Goto K, Takayanagi R, Nawata H (2004) Coregulator- related diseases. Intern Med 43: 368-373.
76. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, et al. (2004) Clinical course of genetic diseases of the insulin receptor (type A and Rabson- Mendenhall syndromes): a 30-year prospective. Medicine (Baltimore) 83: 209- 222.
77. Froesch ER, Zapf J (1985) Insulin-like growth factors and insulin: comparative aspects. Diabetologia 28: 485-493.
論文の公開元へ
